OnabotulinumtoxinA for idiopathic overactive bladder symptoms: Many answers but more questions

摘要

Overactive bladder (OAB) symptoms are highly prevalent and affect around 20% of individuals above the age of 60, regardless of sex. Demographic changes in upcoming decades underscore the socioeconomic importance of this disorder. Antimuscarinics remain the first-line management for OAB, yet high discontinuation rates-up to 60-80% within 12 mo-highlight the need for effective alternative therapeutic approaches.